Cargando…

Reattachment After Foldable Capsular Vitreous Body Implantation in Severe Retinal Detachment Eyes

PURPOSE: To evaluate the clinical effectiveness and safety of foldable capsular vitreous body (FCVB) implantation for severe retinal detachment. METHODS: A retrospective analysis was performed on 26 patients with severe ocular trauma and one with recurrent retinal detachment. Clinical data—including...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Sheng, Tian, Meiwen, Zhang, Liang, Hu, Chenli, Liu, Ke, Qin, Bo, Liu, Shenwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431979/
https://www.ncbi.nlm.nih.gov/pubmed/34491287
http://dx.doi.org/10.1167/tvst.10.11.8
_version_ 1783751057934909440
author Chen, Sheng
Tian, Meiwen
Zhang, Liang
Hu, Chenli
Liu, Ke
Qin, Bo
Liu, Shenwen
author_facet Chen, Sheng
Tian, Meiwen
Zhang, Liang
Hu, Chenli
Liu, Ke
Qin, Bo
Liu, Shenwen
author_sort Chen, Sheng
collection PubMed
description PURPOSE: To evaluate the clinical effectiveness and safety of foldable capsular vitreous body (FCVB) implantation for severe retinal detachment. METHODS: A retrospective analysis was performed on 26 patients with severe ocular trauma and one with recurrent retinal detachment. Clinical data—including surgery success, complications, retinal reattachment, vision, and intraocular pressure (IOP)—were analyzed for patients who underwent 23G pars plana vitrectomy and FCVB implantation combined with silicone oil tamponade. RESULTS: The mean follow-up period was 10.44 ± 2.68 months. All surgeries were smooth; the FCVBs were properly positioned and supported the retina well, and the retinal reattachment rate reached 92.59%. At the six-month follow-up, preoperative (1.30 ± 1.20) and postoperative (0.63 ± 0.79) vision was significantly different (t = 3.03, P = 0.005), and the postoperative IOP (7.93 ± 3.57 mm Hg) was lower than the preoperative IOP (13.98 ± 10.72 mm Hg) (t = 2.74, P = 0.01). Among 20 patients followed up for >12 months, preoperative (1.20 ± 0.95) and postoperative (0.75 ± 0.91) visions were significantly different (t = 1.831, P = 0.005), and the postoperative IOP (9.85 ± 6.48 mm Hg) was lower than the preoperative IOP (14.85 ± 12.17 mm Hg) (t = 1.82, P = 0.01). No endophthalmitis, sympathetic ophthalmia, and rejection of FCVB occurred during follow-up. CONCLUSIONS: FCVB combined with silicone oil tamponade showed good efficacy and safety in severe retinal detachment treatment during the follow-up period. TRANSLATIONAL RELEVANCE: Vitreous substitution is deemed a highly challenging and interesting research topic in ophthalmology. Traditional method such as silicone oil tamponade often causes various complications such as silicone oil emulsification, silicone oil migration, and corneal degeneration. The foldable capsular vitreous body as a novel vitreous substitute combined silicone oil injection into it can stay in the eyeball for a long time without obvious complications.
format Online
Article
Text
id pubmed-8431979
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-84319792021-09-24 Reattachment After Foldable Capsular Vitreous Body Implantation in Severe Retinal Detachment Eyes Chen, Sheng Tian, Meiwen Zhang, Liang Hu, Chenli Liu, Ke Qin, Bo Liu, Shenwen Transl Vis Sci Technol Article PURPOSE: To evaluate the clinical effectiveness and safety of foldable capsular vitreous body (FCVB) implantation for severe retinal detachment. METHODS: A retrospective analysis was performed on 26 patients with severe ocular trauma and one with recurrent retinal detachment. Clinical data—including surgery success, complications, retinal reattachment, vision, and intraocular pressure (IOP)—were analyzed for patients who underwent 23G pars plana vitrectomy and FCVB implantation combined with silicone oil tamponade. RESULTS: The mean follow-up period was 10.44 ± 2.68 months. All surgeries were smooth; the FCVBs were properly positioned and supported the retina well, and the retinal reattachment rate reached 92.59%. At the six-month follow-up, preoperative (1.30 ± 1.20) and postoperative (0.63 ± 0.79) vision was significantly different (t = 3.03, P = 0.005), and the postoperative IOP (7.93 ± 3.57 mm Hg) was lower than the preoperative IOP (13.98 ± 10.72 mm Hg) (t = 2.74, P = 0.01). Among 20 patients followed up for >12 months, preoperative (1.20 ± 0.95) and postoperative (0.75 ± 0.91) visions were significantly different (t = 1.831, P = 0.005), and the postoperative IOP (9.85 ± 6.48 mm Hg) was lower than the preoperative IOP (14.85 ± 12.17 mm Hg) (t = 1.82, P = 0.01). No endophthalmitis, sympathetic ophthalmia, and rejection of FCVB occurred during follow-up. CONCLUSIONS: FCVB combined with silicone oil tamponade showed good efficacy and safety in severe retinal detachment treatment during the follow-up period. TRANSLATIONAL RELEVANCE: Vitreous substitution is deemed a highly challenging and interesting research topic in ophthalmology. Traditional method such as silicone oil tamponade often causes various complications such as silicone oil emulsification, silicone oil migration, and corneal degeneration. The foldable capsular vitreous body as a novel vitreous substitute combined silicone oil injection into it can stay in the eyeball for a long time without obvious complications. The Association for Research in Vision and Ophthalmology 2021-09-07 /pmc/articles/PMC8431979/ /pubmed/34491287 http://dx.doi.org/10.1167/tvst.10.11.8 Text en Copyright 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Article
Chen, Sheng
Tian, Meiwen
Zhang, Liang
Hu, Chenli
Liu, Ke
Qin, Bo
Liu, Shenwen
Reattachment After Foldable Capsular Vitreous Body Implantation in Severe Retinal Detachment Eyes
title Reattachment After Foldable Capsular Vitreous Body Implantation in Severe Retinal Detachment Eyes
title_full Reattachment After Foldable Capsular Vitreous Body Implantation in Severe Retinal Detachment Eyes
title_fullStr Reattachment After Foldable Capsular Vitreous Body Implantation in Severe Retinal Detachment Eyes
title_full_unstemmed Reattachment After Foldable Capsular Vitreous Body Implantation in Severe Retinal Detachment Eyes
title_short Reattachment After Foldable Capsular Vitreous Body Implantation in Severe Retinal Detachment Eyes
title_sort reattachment after foldable capsular vitreous body implantation in severe retinal detachment eyes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431979/
https://www.ncbi.nlm.nih.gov/pubmed/34491287
http://dx.doi.org/10.1167/tvst.10.11.8
work_keys_str_mv AT chensheng reattachmentafterfoldablecapsularvitreousbodyimplantationinsevereretinaldetachmenteyes
AT tianmeiwen reattachmentafterfoldablecapsularvitreousbodyimplantationinsevereretinaldetachmenteyes
AT zhangliang reattachmentafterfoldablecapsularvitreousbodyimplantationinsevereretinaldetachmenteyes
AT huchenli reattachmentafterfoldablecapsularvitreousbodyimplantationinsevereretinaldetachmenteyes
AT liuke reattachmentafterfoldablecapsularvitreousbodyimplantationinsevereretinaldetachmenteyes
AT qinbo reattachmentafterfoldablecapsularvitreousbodyimplantationinsevereretinaldetachmenteyes
AT liushenwen reattachmentafterfoldablecapsularvitreousbodyimplantationinsevereretinaldetachmenteyes